calendar
3,176 catalysts · 3,288 8k filing · 2,079 grant · 1,097 approval · 1,000 device adverse event · 800 device 510k · 584 earnings
3,176 catalysts · 3,288 8k filing · 2,079 grant · 1,097 approval · 1,000 device adverse event · 800 device 510k · 584 earnings
no tagged catalysts yet
Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: KENVUE BRANDS. Form: AEROSOL, FOAM. Route: TOPICAL
Sponsor: MSN. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL
Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: TOPICAL
Sponsor: AMNEAL. Form: TABLET. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: CELLTRION INC. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: LAURUS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: LAURUS. Form: CAPSULE. Route: ORAL
Sponsor: SOMERSET THERAPS LLC. Form: TABLET
Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL
Sponsor: ORBICULAR. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: RISING. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: TOPICAL
Sponsor: SANDOZ. Form: TABLET. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET. Route: ORAL
Sponsor: PHARMACHEMIE BV. Form: INJECTABLE. Route: INJECTION
Sponsor: PHARMACHEMIE BV. Form: INJECTABLE. Route: INJECTION
Sponsor: RISING. Form: CAPSULE. Route: ORAL
GM grant. $196,875. PI: Stephania A Cormier
Sponsor: AJANTA PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL
Sponsor: KADMON PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: ACCORD BIOPHARMA INC.. Form: INJECTABLE. Route: INJECTION
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: WATSON LABS. Form: TABLET. Route: ORAL
Sponsor: ADIENNE SA. Form: POWDER. Route: INTRAVENOUS
Sponsor: SHANDONG. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: TEVA PHARMS INC. Form: TABLET. Route: ORAL
AG grant. $293,454. PI: Caitlin R. Bowman
GM grant. $223,500. PI: KayLoni L. Olson
NS grant. $943,253. PI: Hideho Okada
DE grant. $699,184. PI: Sukirth Murthy Ganesan
AG grant. $466,125. PI: Valentina Mazzoli
AG grant. $476,159. PI: Martin Hruska